LegoChem Biosciences Inc (141080) - Net Assets

Latest as of March 2026: ₩500.52 Billion KRW ≈ $339.20 Million USD

Based on the latest financial reports, LegoChem Biosciences Inc (141080) has net assets worth ₩500.52 Billion KRW (≈ $339.20 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩652.93 Billion ≈ $442.48 Million USD) and total liabilities (₩152.41 Billion ≈ $103.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LegoChem Biosciences Inc (141080) tangible net worth to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩500.52 Billion
% of Total Assets	76.66%
Annual Growth Rate	34.93%
5-Year Change	109.11%
10-Year Change	800.96%
Growth Volatility	99.21

LegoChem Biosciences Inc - Net Assets Trend (2014–2025)

This chart illustrates how LegoChem Biosciences Inc's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of LegoChem Biosciences Inc to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for LegoChem Biosciences Inc (2014–2025)

The table below shows the annual net assets of LegoChem Biosciences Inc from 2014 to 2025. For live valuation and market cap data, see LegoChem Biosciences Inc market cap and net worth.

Year	Net Assets	Change
2025-12-31	₩541.12 Billion ≈ $366.71 Million	-12.16%
2024-12-31	₩616.00 Billion ≈ $417.45 Million	+315.59%
2023-12-31	₩148.22 Billion ≈ $100.45 Million	-32.50%
2022-12-31	₩219.60 Billion ≈ $148.82 Million	-15.14%
2021-12-31	₩258.77 Billion ≈ $175.37 Million	+130.79%
2020-12-31	₩112.13 Billion ≈ $75.99 Million	-1.43%
2019-12-31	₩113.75 Billion ≈ $77.09 Million	+11.89%
2018-12-31	₩101.66 Billion ≈ $68.90 Million	+110.89%
2017-12-31	₩48.21 Billion ≈ $32.67 Million	-19.74%
2016-12-31	₩60.06 Billion ≈ $40.70 Million	+39.10%
2015-12-31	₩43.18 Billion ≈ $29.26 Million	+115.42%
2014-12-31	₩20.04 Billion ≈ $13.58 Million	--

Equity Component Analysis

This analysis shows how different components contribute to LegoChem Biosciences Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 24023925800000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩211.81 Billion	41.73%
Other Components	₩295.81 Billion	58.27%
Total Equity	₩507.61 Billion	100.00%

LegoChem Biosciences Inc Competitors by Market Cap

The table below lists competitors of LegoChem Biosciences Inc ranked by their market capitalization.

Company	Market Cap
Amedisys Inc NASDAQ:AMED	$3.32 Billion
Guangdong HongDa Blasting Co Ltd SHE:002683	$3.32 Billion
Hefei Chipmore Technology Co. Ltd. A SHG:688352	$3.32 Billion
China Railway Construction Heavy Industry Corp Ltd SHG:688425	$3.32 Billion
Shanghai Suochen Information Technology Co. Ltd. A SHG:688507	$3.32 Billion
CI Financial Corp TO:CIX	$3.32 Billion
Xiamen Changelight SHE:300102	$3.32 Billion
Jiangsu Huahong Technology Co Ltd SHE:002645	$3.32 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in LegoChem Biosciences Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 615,998,105,850 to 507,613,912,380, a change of -108,384,193,470 (-17.6%).
Net loss of 74,277,654,740 reduced equity.
Share repurchases of 6,996,191,000 reduced equity.
New share issuances of 7,238,893,000 increased equity.
Other factors decreased equity by 34,349,240,730.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-74.28 Billion	-14.63%
Share Repurchases	₩7.00 Billion	-1.38%
Share Issuances	₩7.24 Billion	+1.43%
Other Changes	₩-34.35 Billion	-6.77%
Total Change	₩-	-17.59%

Book Value vs Market Value Analysis

This analysis compares LegoChem Biosciences Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 9.65x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 44.56x to 9.65x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩3020.78	₩134600.00	x
2017-12-31	₩2421.32	₩134600.00	x
2018-12-31	₩4800.09	₩134600.00	x
2019-12-31	₩5304.51	₩134600.00	x
2020-12-31	₩4734.30	₩134600.00	x
2021-12-31	₩10677.76	₩134600.00	x
2022-12-31	₩8610.70	₩134600.00	x
2023-12-31	₩5566.42	₩134600.00	x
2024-12-31	₩16978.06	₩134600.00	x
2025-12-31	₩13943.47	₩134600.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently LegoChem Biosciences Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -14.63%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -52.47%
• Asset Turnover: 0.20x
• Equity Multiplier: 1.38x
Recent ROE (-14.63%) is above the historical average (-18.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-43.33%	-998.29%	0.03x	1.68x	₩-10.69 Billion
2015	-19.08%	-460.58%	0.03x	1.59x	₩-12.56 Billion
2016	-24.52%	-88.41%	0.19x	1.49x	₩-20.73 Billion
2017	-26.83%	-58.64%	0.27x	1.71x	₩-17.75 Billion
2018	-25.35%	-102.10%	0.21x	1.20x	₩-35.94 Billion
2019	11.94%	23.63%	0.41x	1.24x	₩2.21 Billion
2020	-6.23%	-14.14%	0.36x	1.21x	₩-18.20 Billion
2021	-9.04%	-72.74%	0.11x	1.13x	₩-49.27 Billion
2022	-20.53%	-134.96%	0.13x	1.15x	₩-67.05 Billion
2023	-49.73%	-215.85%	0.18x	1.28x	₩-88.53 Billion
2024	1.27%	6.20%	0.17x	1.20x	₩-53.80 Billion
2025	-14.63%	-52.47%	0.20x	1.38x	₩-125.04 Billion

Industry Comparison

This section compares LegoChem Biosciences Inc's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $220,072,755,126
Average return on equity (ROE) among peers: -0.64%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
LegoChem Biosciences Inc (141080)	₩500.52 Billion	-43.33%	0.30x	$3.32 Billion
ORIENTBIO Inc. (002630)	$83.19 Billion	41.11%	0.26x	$69.43 Million
Green Cross (005250)	$282.15 Billion	18.83%	0.53x	$325.83 Million
Green Cross Holdings Preference Shares (005257)	$1.31 Trillion	5.00%	0.57x	$3.22 Million
Pharmicell (005690)	$94.60 Billion	-0.72%	0.08x	$546.93 Million
GeneOne Life Science Inc (011000)	$35.85 Billion	-43.51%	0.83x	$42.64 Million
HLB Co. Ltd (028300)	$174.68 Billion	14.51%	0.74x	$4.28 Billion
Daesung Microbiological Labs. Co. Ltd (036480)	$37.00 Billion	2.34%	0.69x	$16.46 Million
Seoulin Bioscience Co.Ltd (038070)	$83.89 Billion	3.47%	0.21x	$29.61 Million
Hyundai Bioscience Co. Ltd (048410)	$18.21 Billion	-44.31%	1.93x	$574.04 Million
iNtRON Biotechnology Inc (048530)	$83.77 Billion	-3.09%	0.03x	$56.99 Million

About LegoChem Biosciences Inc

KQ:141080 Korea Biotechnology

Market Cap

$3.32 Billion

₩4.90 Trillion KRW

Market Cap Rank

#4726 Global

#118 in Korea

Share Price

₩134600.00

Change (1 day)

+0.07%

52-Week Range

₩104200.00 - ₩213500.00

All Time High

₩213500.00